FERRARI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 499
EU - Europa 317
AS - Asia 201
AF - Africa 3
SA - Sud America 2
OC - Oceania 1
Totale 1.023
Nazione #
US - Stati Uniti d'America 495
CN - Cina 99
UA - Ucraina 89
GB - Regno Unito 51
DE - Germania 45
IT - Italia 40
SG - Singapore 35
FI - Finlandia 32
TR - Turchia 23
HK - Hong Kong 22
IE - Irlanda 17
IN - India 15
PL - Polonia 14
FR - Francia 12
SE - Svezia 12
CA - Canada 4
VN - Vietnam 4
MU - Mauritius 3
BR - Brasile 2
NL - Olanda 2
AU - Australia 1
AZ - Azerbaigian 1
ES - Italia 1
ID - Indonesia 1
IM - Isola di Man 1
JP - Giappone 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.023
Città #
Chandler 78
Jacksonville 65
Fairfield 37
Ashburn 36
Princeton 32
Singapore 32
Woodbridge 31
Beijing 23
Hong Kong 22
Lancaster 21
Houston 20
Nanjing 19
Dublin 17
Istanbul 17
Wilmington 15
Cambridge 14
Warsaw 14
Ann Arbor 12
Helsinki 11
Lappeenranta 10
Milan 10
Seattle 10
Shanghai 10
Des Moines 9
Dearborn 8
New York 8
Changsha 7
Nanchang 7
Hebei 6
Tianjin 5
Dong Ket 4
Jiaxing 4
Kocaeli 4
Changchun 3
Kulgam 3
Kunming 3
London 3
Rome 3
Toronto 3
Zhengzhou 3
Cassino 2
Jinan 2
Manocalzati 2
Ningbo 2
San Diego 2
Shenyang 2
Spino d'Adda 2
São Paulo 2
Almere Stad 1
Ankara 1
Baku 1
Bergamo 1
Bratislava 1
Brecon 1
Brescia 1
Canberra 1
Douglas 1
Eindhoven 1
Frankfurt am Main 1
Hangzhou 1
Hefei 1
Jakarta 1
Lanzhou 1
Leawood 1
Markham 1
Monza 1
Mumbai 1
Munich 1
Naples 1
Norwalk 1
Orange 1
Pune 1
Redwood City 1
Romola 1
San Francisco 1
San Paolo 1
Tokyo 1
Washington 1
Totale 685
Nome #
Effects of serelaxin in patients with acute heart failure 124
Acute hemodynamic and neurohumoral effects of the oral dopamine derivative ibopamine in patients with heart failure. 81
Beta bloccanti e angina instabile. 77
Valutazione emodinamica e neurormonale di tre agenti dopaminergici in pazienti con grave insufficienza cardiaca. 75
Comparison of the neurohumoral effects of dopamine and ibopamine in patients with heart failure. 67
L'azione della digitale sul cuore normale e patologico 65
Exercise tolerance and muscle metabolism in patient with heart failure. 59
Effects of the selective DA2 agonist dihydroergotoxine in patients with heart failure. 56
Crisi parziali? Pseudocrisi? In paziente con QT lungo 56
Correlazioni tra modificazioni emodinamiche e attivazione simpatica durante sforzo in pazienti con insufficienza cardiaca cronica. 55
Nuovi agenti inotropi. Quali vantaggi rispetto alla digitale? 53
Acute and chronic effects of nisoldipine in patients with heart failure. 51
Heart Failure Association of the European Society of Cardiology update on sodium–glucose co-transporter 2 inhibitors in heart failure 50
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 49
Sodium glucose co-transporter-2 inhibitors in heart failure: beyond glycaemic control. The Position Paper of the Heart Failure Association of the European Society of Cardiology 42
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials 39
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology 21
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology 18
Comprehensive Characterization of Non-Cardiac Comorbidities in Acute Heart Failure- an analysis of ESC-HFA EORP Heart Failure Long-Term Registry 11
Totale 1.049
Categoria #
all - tutte 6.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 10 23 10 20 8 32 13 12
2020/2021193 6 14 8 19 7 24 7 25 30 22 22 9
2021/2022124 3 24 3 6 2 4 5 4 8 20 12 33
2022/2023187 17 2 3 16 16 48 0 27 36 0 10 12
2023/2024122 6 7 22 3 3 11 3 13 24 10 3 17
2024/2025101 13 4 17 40 27 0 0 0 0 0 0 0
Totale 1.049